PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE | Patent Publication Number 20150265536

US 20150265536 A1
Patent Number-
Application Number14363004
Filled DateDec 7, 2012
Priority DateDec 9, 2011
Publication DateSep 24, 2015
Original AssigneePurdue Pharma
Current AssigneePurdue Pharma
Inventor/Applicants
International
1
A61K
National
0
Field of Search
0

The present invention relates to a solid extended release pharmaceutical dosage form, comprising a mixture in the form of an extended release matrix formulation, the mixture comprising at least: (1) at least one poly(ε-caprolactone), and (2) at least one polyethylene oxide, and (3) at least one active agent.

  • 5. A solid extended release pharmaceutical dosage form, comprising a mixture in the form of an extended release matrix formulation, the mixture comprising at leastn(1) at least one poly(ε-caprolactone) having an approximate number average molecular weight of more than 43,000, and(2) at least one polyethylene oxide, and(3) at least one active agent.
  • 3-4. (canceled)
  • 116. (canceled)
  • 7-18. (canceled)
  • 21-38. (canceled)
  • 40-48. (canceled)
  • 50-61. (canceled)
  • 69-73. (canceled)
  • 83-84. (canceled)
  • 87-88. (canceled)
  • 91-95. (canceled)
  • 98.-100. (canceled)
  • 103-109. (canceled)
  • 118-121. (canceled)
  • 123.-124. (canceled)
  • 127-130. (canceled)
  • 132-133. (canceled)
  • 135-137. (canceled)
  • 139-141. (canceled)
  • 143.-146. (canceled)
  • 148.-150. (canceled)
  • 152-176. (canceled)
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Subscription-Only
View Concierge Program
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.